Table 4.
Checklist to Evaluate A Report of a Nonpharmacologic Trial (CLEAR-NPT) scoring for each item in each study after contacting the authors.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Total score | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Archetti Netto15 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 18 |
Bottoni et al.16 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | N/A | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 18 |
Castagna Poehling and Freehill17 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 18 |
Elmlund et al.18 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 18 |
Hiemstra et al.20 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | No | Yes | No | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 16 |
Magnusson et al.22 | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | Yes | N/A | Yes | Yes | Yes | 16 |
McRae et al.24 | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 17 |
Monteiro et al.27 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 17 |
Mohtadi et al.26 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | No | Yes | No | Yes | Yes | No | NR | Yes | Yes | Yes | 14 |
Salomonsson et al.32 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | yes | Yes | Yes | Yes | 17 |
Warme et al.35 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 17 |
The result of each study is shown regarding each item of the CLEAR-NPT scoring. The rows represent the items of the modified CLEAR-NPT as stated in Appendix 2.